Drug name - Tobradex St
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8101582 | EYEVANCE | Topical ophthalmic compositions containing tobramycin and dexamethasone |
Dec, 2027
(5 years from now) | |
| US8450287 | EYEVANCE | Topical ophthalmic compositions containing tobramycin and dexamethasone |
Dec, 2027
(5 years from now) | |
| US7795316 | EYEVANCE | Topical ophthalmic compositions containing tobramycin and dexamethasone |
Aug, 2028
(5 years from now) | |
Drugs and Companies using DEXAMETHASONE; TOBRAMYCIN ingredient
Treatment: Use of a combination of tobramycin and dexamethasone to treat ocular inflammation where an infection or risk of infection exists
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.05%;0.3% | SUSPENSION/DROPS;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.